ADVERSE REACTIONS An increased risk of the following serious adverse reactions has been associated with the use of oral contra-ceptives (See WARNINGS Section). ° Thrombophlebitis and venous thrombosis with or without embolism ° Arterial thromboembolism ° Pulmonary embolism ° Myocardial infarction ° Cerebral hemorrhage ° Cerebral thrombosis ° Hypertension ° Gallbladder disease ° Hepatic adenomas or benign liver tumors There is evidence of an association between the following conditions and the use of oral contraceptives: ° Mesenteric thrombosis ° Retinal thrombosis The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related: ° Nausea ° Vomiting ° Gastrointestinal symptoms (such as abdominal cramps and bloating) ° Breakthrough bleeding ° Spotting ° Change in menstrual flow ° Amenorrhea ° Temporary infertility after discontinuation of treatment ° Edema ° Melasma which may persist ° Breast changes: tenderness, enlargement, secretion ° Change in weight (increase or decrease) ° Change in cervical erosion and secretion ° Diminution in lactation when given immediately postpartum ° Cholestatic jaundice ° Migraine ° Rash (allergic) ° Mental depression ° Reduced tolerance to carbohydrates ° Vaginal candidiasis ° Change in corneal curvature (steepening) ° Intolerance to contact lenses The following adverse reactions have been reported in users of oral contraceptives and a causal association has been neither confirmed nor refuted: ° Pre-menstrual syndrome ° Cataracts ° Changes in appetite ° Cystitis-like syndrome ° Headache ° Nervousness ° Dizziness ° Hirsutism ° Loss of scalp hair ° Erythema multiforme ° Erythema nodosum ° Hemorrhagic eruption ° Vaginitis ° Porphyria ° Impaired renal function ° Hemolytic uremic syndrome ° Acne ° Changes in libido ° Colitis ° Budd-Chiari Syndrome | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
